The Unresolved Challenge in Primary Prevention Cardiovascular diseases (CVDs), principally ischemic heart disease and stroke, remain the leading drivers of global mortality. 1 While aspirin has historically served as a cornerstone of primary prevention due to its antiplatelet activity, landmark clinical trials demonstrate that its cardioprotective benefit is frequently counterbalanced by a significant risk of bleeding events.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Roth
Contact Roth, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack